COMPOSITIONS AND THEIR USE FOR THE TREATMENT OF .ALPHA.1-ANTITRYPSIN DEFICIENCY
The invention relates to pharmaceutical compositions comprising (S)-1-((2-(trifluoromethyl)phenyl)sulfonyl)piperidine-3-carboxylic acid and their medical use, for example for use in the treatment of ?1-antitrypsin deficiency (AATD). L'invention concerne des compositions pharmaceutiques comprena...
Saved in:
| Main Authors | , , |
|---|---|
| Format | Patent |
| Language | English French |
| Published |
22.12.2022
|
| Online Access | Get full text |
Cover
Loading…
| Abstract | The invention relates to pharmaceutical compositions comprising (S)-1-((2-(trifluoromethyl)phenyl)sulfonyl)piperidine-3-carboxylic acid and their medical use, for example for use in the treatment of ?1-antitrypsin deficiency (AATD).
L'invention concerne des compositions pharmaceutiques comprenant de l'acide (S)-1-((2-(trifluorométhyl)phényl)sulfonyl)pipéridine-3-carboxylique et leur utilisation médicale, par exemple dans le traitement d'une déficience en ?1-antitrypsine (AATD). |
|---|---|
| AbstractList | The invention relates to pharmaceutical compositions comprising (S)-1-((2-(trifluoromethyl)phenyl)sulfonyl)piperidine-3-carboxylic acid and their medical use, for example for use in the treatment of ?1-antitrypsin deficiency (AATD).
L'invention concerne des compositions pharmaceutiques comprenant de l'acide (S)-1-((2-(trifluorométhyl)phényl)sulfonyl)pipéridine-3-carboxylique et leur utilisation médicale, par exemple dans le traitement d'une déficience en ?1-antitrypsine (AATD). |
| Author | RAMSDEN, NIGEL HUNTINGTON, JAMES ANDREW FOX, DAVID JOHN |
| Author_xml | – fullname: RAMSDEN, NIGEL – fullname: FOX, DAVID JOHN – fullname: HUNTINGTON, JAMES ANDREW |
| BookMark | eNqNyk0KwjAQQOEsdOHfHeYCLaY5wZBO6IBNQjIuuipF4kraQr0_IngAV48P3lHt5mUuBxVs6GPILBx8BvQtSEec4J4JXEhfgSRC6ckLBAc13mKHta7QC0saYmYPLTm2TN4OZ7V_Tq-tXH49KXAktqvKuoxlW6dHmct7tGiaxmhzRW3-WD4AEy_C |
| ContentType | Patent |
| DBID | EVB |
| DatabaseName | esp@cenet |
| DatabaseTitleList | |
| Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Chemistry Sciences |
| DocumentTitleAlternate | COMPOSITIONS ET LEUR UTILISATION DANS LE TRAITEMENT D'UNE DEFICIENCE EN .ALPHA.1-ANTITRYPSINE |
| ExternalDocumentID | CA3223130A1 |
| GroupedDBID | EVB |
| ID | FETCH-epo_espacenet_CA3223130A13 |
| IEDL.DBID | EVB |
| IngestDate | Fri Aug 23 06:55:57 EDT 2024 |
| IsOpenAccess | true |
| IsPeerReviewed | false |
| IsScholarly | false |
| Language | English French |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-epo_espacenet_CA3223130A13 |
| Notes | Application Number: CA20223223130 |
| OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20221222&DB=EPODOC&CC=CA&NR=3223130A1 |
| ParticipantIDs | epo_espacenet_CA3223130A1 |
| PublicationCentury | 2000 |
| PublicationDate | 20221222 |
| PublicationDateYYYYMMDD | 2022-12-22 |
| PublicationDate_xml | – month: 12 year: 2022 text: 20221222 day: 22 |
| PublicationDecade | 2020 |
| PublicationYear | 2022 |
| RelatedCompanies | CENTESSA PHARMACEUTICALS (UK) LIMITED |
| RelatedCompanies_xml | – name: CENTESSA PHARMACEUTICALS (UK) LIMITED |
| Score | 3.4424133 |
| Snippet | The invention relates to pharmaceutical compositions comprising (S)-1-((2-(trifluoromethyl)phenyl)sulfonyl)piperidine-3-carboxylic acid and their medical use,... |
| SourceID | epo |
| SourceType | Open Access Repository |
| Title | COMPOSITIONS AND THEIR USE FOR THE TREATMENT OF .ALPHA.1-ANTITRYPSIN DEFICIENCY |
| URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20221222&DB=EPODOC&locale=&CC=CA&NR=3223130A1 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3NT8IwFG8IGvWmqBG_0oPZbQjbYOywmNJ12YxsyygGToRCl3AZRGb8931tAL3orR9J076832tf-96vCD2Jpeu6c5XR0xFtUymJOe96jmn3e45UR3Kn0GyfSS8aO6-T7qSGVvtcGM0T-qXJEQFRC8B7pe315ucSK9CxldtnsYKm9UvI_cDYeccWGGLLMoKBz7I0SKlBqU-JkeQ-6K0N5pqAo3QEp2hXgYG9D1RSyub3jhKeo-MMBiurC1STZQOd0v3Haw10Mty9d0NxB73tJUppOszSUazTfjFJAswjFud4PGIYPDlVwzxnhCt2fpyGuEXesoi0OiZJeMzzaTaKExywMNbXStMrhEPGaWTCzGYHKcwoOazBvkb1cl3KG4S9edHuiYUnXZCw6Ii-9JayaNu2YsbzCq-Jmn8Oc_tP3x06U-JUgRuWdY_q1cenfIDttxKPWnDfYOOBSQ |
| link.rule.ids | 230,309,783,888,25576,76876 |
| linkProvider | European Patent Office |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3NT8IwFH8haMSbokb87MHsNoRtMHZYTOm6bArbMoqBE2HQJVwGkRn_fdsG0Ive-pE07cv7vfa17_0K8JQtbduey4yedtbSpZLo845j6Wava3F5JLdyxfYZdYOx9TrpTCqw2ufCKJ7QL0WOKBC1EHgvlb3e_FxieSq2cvucrUTT-sVnrqftvGNDGGLD0Ly-S5PYi4lGiEuwFqWu0FtTmGssHKUjccK2JRjoe18mpWx-7yj-GRwnYrCiPIcKL-pQI_uP1-pwMty9d4viDnrbC4hJPEziUajSfhGOPMQCGqZoPKJIeHKyhlhKMZPs_Cj2URMPkgA32zqOWMjSaTIKI-RRP1TXStNLQD5lJNDFzGYHKcwIPqzBvIJqsS74NSBnnre62cLhtpBw1s563FnyvGWakhnPyZ0GNP4c5uafvkeoBWw4mA3C6O0WTqVoZRCHYdxBtfz45PdiKy6zByXEb51chDw |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=COMPOSITIONS+AND+THEIR+USE+FOR+THE+TREATMENT+OF+.ALPHA.1-ANTITRYPSIN+DEFICIENCY&rft.inventor=RAMSDEN%2C+NIGEL&rft.inventor=FOX%2C+DAVID+JOHN&rft.inventor=HUNTINGTON%2C+JAMES+ANDREW&rft.date=2022-12-22&rft.externalDBID=A1&rft.externalDocID=CA3223130A1 |